SCHEMBL1245355

SCHEMBL1245355

COC(=O)COc1ccc(C(C)=O)cc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
HTT P42858 1/20 0.54
MAPT P10636 4/20 0.50
LMNA P02545 2/20 0.49
KDM4E B2RXH2 2/20 0.49
KCNH2 Q12809 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
HIF1A Q16665 1/20 0.49
POLB P06746 1/20 0.47
MEN1 O00255 2/20 0.46
TSHR P16473 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
CREBBP Q92793 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8023008 0.88 KMT2A (0.55) KMT2AHTTLMNACYP1A2CYP2C9
SCHEMBL7361563 0.87 KMT2A (0.65) KMT2AHTTMAPTLMNAKDM4E
SCHEMBL2439155 0.86 KMT2A (0.57) KMT2AMAPTKDM4ECYP1A2CYP2C9
SCHEMBL11658983 0.84 KMT2A (0.74) KMT2AHTTCYP1A2CYP2C9MEN1
SCHEMBL3014488 0.84 PTGDR2 (0.53) KMT2AMAPTLMNAKDM4EKCNH2
SCHEMBL7335355 0.84 HTT (0.51) HTTMAPTLMNAKDM4EKCNH2
SCHEMBL3015438 0.84 MAPT (0.49) KMT2AMAPTLMNAKDM4EKCNH2
SCHEMBL3006207 0.84 ESR1 (0.56) KMT2AMAPTLMNAKDM4EKCNH2
SCHEMBL987758 0.83 KMT2A (0.53) KMT2AMAPTLMNAKDM4ECYP1A2
SCHEMBL4887579 0.83 CYP1A2 (0.69) KMT2AHTTMAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230416210-A1 METHODS OF MAKING A PPAR-DELTA AGONIST RENEO PHARMACEUTICALS, INC. 2023-12-28 US disclosed
EP-4251144-A1 METHODS OF MAKING A PPAR-DELTA AGONIST Reneo Pharmaceuticals, Inc. (US) 2023-10-04 EP disclosed
CN-116761596-A Methods of making PPAR-delta agonists 雷内奥制药公司 2023-09-15 CN disclosed
WO-2022115326-A1 METHODS OF MAKING A PPAR-DELTA AGONIST RENEO PHARMACEUTICALS, INC. (US) 2022-06-02 WO disclosed
WO-2022115326-A1 METHODS OF MAKING A PPAR-DELTA AGONIST RENEO PHARMACEUTICALS, INC. (US) 2022-06-02 WO disclosed
US-20210188758-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS VTVX HOLDINGS II LLC 2021-06-24 US disclosed
US-10947180-B2 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists VTV THERAPEUTICS LLC (US) 2021-03-16 US disclosed
US-20200215073-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS HIGH POINT PHARMACEUTICALS, LLC 2020-07-09 US disclosed
US-10471066-B2 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists VTV THERAPEUTICS LLC (US) 2019-11-12 US disclosed
US-20180071304-A1 Phenoxy Acetic Acids and Phenyl Propionic Acids as PPAR Delta Agonists HIGH POINT PHARMACEUTICALS, LLC 2018-03-15 US disclosed
US-5728701-A INHIBIT PLATELET AGGREGATION ZENECA LIMITED (GB) 1998-03-17 US disclosed
EP-0825184-A1 Heterocyclic derivatives as platelet aggregation inhibitors ZENECA LIMITED (GB) 1998-02-25 EP disclosed
US-5652242-A 3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL)PHENOXY)BURYIC ACID, AMIDE OR ESTER; INHIBITORS OF BINDING OF FIBRINOGEN TO GLYCOPROTEIN ZENECA LIMITED (GB) 1997-07-29 US disclosed
US-5563141-A INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION ZENECA LIMITED (GB) 1996-10-08 US disclosed
US-5556977-A ANTIAGGLOMERANTS FOR CELLS, ANTICOAGULANTS, ANTIISCHEMIC AGENTS USING PYRIDINYLPIPERAZINE DERIVATIVES ZENECA LIMITED (GB) 1996-09-17 US disclosed
CN-1120334-A Heterocyclic derivatives as platelet aggregation inhibitors ZENECA LTD (GB) 1996-04-10 CN disclosed
EP-0691959-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-17 EP disclosed
EP-0690847-A1 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-10 EP disclosed
WO-1994022835-A2 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed
WO-1994022834-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10471066-B2 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists PPARG, PPARA, PPARD KMT2A 3345/4885HTT 1592/4885MAPT 1900/4885
US-20230416210-A1 METHODS OF MAKING A PPAR-DELTA AGONIST PPARA, PPARG, PPARD KMT2A 2641/4885HTT 3742/4885MAPT 4728/4885
US-10947180-B2 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists PPARG, PPARA, PPARD KMT2A 3345/4885HTT 1592/4885MAPT 1900/4885
US-20180071304-A1 Phenoxy Acetic Acids and Phenyl Propionic Acids as PPAR Delta Agonists PPARG, PPARA, PPARD KMT2A 3345/4885HTT 1592/4885MAPT 1900/4885
US-20200215073-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS PPARG, PPARA, PPARD KMT2A 3345/4885HTT 1592/4885MAPT 1900/4885
US-20210188758-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS PPARG, PPARA, PPARD KMT2A 3345/4885HTT 1592/4885MAPT 1900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.